Episode
Episode 826: Beyond Implants: How Conexeu’s ($CNXU) B.R.E.A.S.T.™ Could Advance Tissue Regeneration
- Podcast
- Stocks To Watch
- Published
- Jun 3, 2026
- Duration seconds
- 1248
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-826-beyond-implants-how-conexeu-s-cnxu-b-r-e-a-s-t-could-advance-tissue-regeneration/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/stocks-to-watch-5696376/episode-826-beyond-implants-how-conexeu-s-cnxu-b-r-e-a-s-t-could-advance-tissue-regeneration.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This interview is disseminated on behalf of Conexeu Sciences Inc. Reconstruction is being redefined with Conexeu Sciences Inc. (NASDAQ: CNXU), as the company recently announced the development of Bio-Regenerative Ergonomically Architected Smart Tissue™ (B.R.E.A.S.T.™), a new approach designed to advance breast reconstruction following mastectomy. In this exclusive interview, Chief Scientific Officer and Co-Founder Dr. Claudia Chavez-Munoz, MD, PhD, outlines the science behind the program, its mechanism of action, and how the company is leveraging its proprietary CXU™ platform to expand across multiple applications. Watch now to find out how B.R.E.A.S.T.™ is designed to potentially help the body rebuild itself. Learn more: https://www.conexeu.com/ Watch the full YouTube interview here: https://youtu.be/N8thuQMx6Z8 And follow us to stay updated: https://www.youtube.com/GlobalOneMedia